Literature DB >> 21131154

Fundamental aspects of chiral electromigration techniques and application in pharmaceutical and biomedical analysis.

Gerhard K E Scriba1.   

Abstract

Capillary electromigration techniques are often considered ideal methods for the analysis of chiral compounds due to the high resolution power and flexibility of the technique. Therefore, especially capillary electrophoresis using a chiral selector in the background electrolyte, also termed electrokinetic chromatography, has found widespread acceptance in analytical enantioseparations of drug compounds in pharmaceuticals and biological media. Moreover, mechanistic studies on analyte complexation by the chiral selectors have continuously been conducted in an effort to rationalize enantioseparation phenomena. These studies combined capillary electrophoresis with spectroscopic techniques such as nuclear magnetic resonance and/or molecular modeling. The present review focuses on recent examples of mechanistic aspects of capillary electromigration enantioseparations and summarizes recent applications of chiral pharmaceutical and biomedical analysis published between January 2009 and August 2010.
Copyright © 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21131154     DOI: 10.1016/j.jpba.2010.11.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Application of Guanidine Hcl to Improve Enantioseparation of a Model Basic Drug, Cetirizine, By Capillary Electrophoresis Using Sulfated Β-Cyclodextrin.

Authors:  Alireza Shafaati; Afshin Zarghi; Farin Sattary Javid
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

2.  Explanation of the Formation of Complexes between Representatives of Oxazolidinones and HDAS-β-CD Using Molecular Modeling as a Complementary Technique to cEKC and NMR.

Authors:  Wojciech Bocian; Elżbieta Bednarek; Katarzyna Michalska
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.